April 4, 2018
Ver artículo completoPlasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Plasma pTau181 may have utility as a biomarker of AD pathophysiology and as a noninvasive screener for elevated brain Aβ.